Abstract
Yellow fever (YF) is frequently associated with high severity and death rates in the Amazon region of Brazil. During the rainy seasons of 1998 and 1999, 23 (eight deaths) and 34 (eight deaths) human cases of YF were reported, respectively, in different geographic areas of Pará State; most cases were on Marajó Island. Patients were 1 to 46 years of age. Epidemiologic and ecological studies were conducted in Afuá and Breves on Marajó Island; captured insects yielded isolates of 4 and 11 YF strains, respectively, from Haemagogus janthinomys pooled mosquitoes. The cases on Marajó Island in 1999 resulted from lack of vaccination near the focus of the disease and intense migration, which brought many nonimmune people to areas where infected vectors were present. We hypothesize that YF virus remains in an area after an outbreak by vertical transmission among Haemagogus mosquitoes.
Full Text
The Full Text of this article is available as a PDF (461.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dégallier N., Travassos da Rosa A. P., Vasconcelos P. F., Guerreiro S. C., Travassos da Rosa J. F., Hervé J. P. Estimation du taux de survie, de la densité relative et du taux d'infection d'une population d'Haemagogus janthinomys Dyar (Diptera, Culicidae) ayant fourni des souches de fièvre jaune en Amazonie Brésilienne. Bull Soc Pathol Exot. 1991;84(4):386–397. [PubMed] [Google Scholar]
- Dégallier N., da Rosa A. P., Vasconcelos P. F., Figueiredo L. T., da Rosa J. F., Rodrigues S. G., da Rosa E. S. La dengue et ses vecteurs au Brésil. Bull Soc Pathol Exot. 1996;89(2):128–136. [PubMed] [Google Scholar]
- GROOT H., RIBERIRO R. B. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bull World Health Organ. 1962;27:699–707. [PMC free article] [PubMed] [Google Scholar]
- Gubler D. J. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. Am J Trop Med Hyg. 1989 Jun;40(6):571–578. doi: 10.4269/ajtmh.1989.40.571. [DOI] [PubMed] [Google Scholar]
- Hall W. C., Crowell T. P., Watts D. M., Barros V. L., Kruger H., Pinheiro F., Peters C. J. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg. 1991 Oct;45(4):408–417. doi: 10.4269/ajtmh.1991.45.408. [DOI] [PubMed] [Google Scholar]
- Kuno G., Gómez I., Gubler D. J. Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1987 Jan;36(1):153–159. doi: 10.4269/ajtmh.1987.36.153. [DOI] [PubMed] [Google Scholar]
- Monath T. P., Nasidi A. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 1993 Feb;48(2):274–299. doi: 10.4269/ajtmh.1993.48.274. [DOI] [PubMed] [Google Scholar]
- Monath T. P. Yellow fever: a medically neglected disease. Report on a seminar. Rev Infect Dis. 1987 Jan-Feb;9(1):165–175. doi: 10.1093/clinids/9.1.165. [DOI] [PubMed] [Google Scholar]
- Mondet B., da Rosa A. P., Vasconcelos P. F. Les risques d'épidémisation urbaine de la fièvre jaune au Brésil par les vecteurs de la dengue. Aedes aegypti et Aedes albopictus. Bull Soc Pathol Exot. 1996;89(2):107–114. [PubMed] [Google Scholar]
- Pinheiro F. P., Travassos da Rosa A. P., Moraes M. A., Almeida Neto J. C., Camargo S., Filgueiras J. P. An epidemic of yellow fever in central Brazil. 1972-1973. I. Epidemiological studies. Am J Trop Med Hyg. 1978 Jan;27(1 Pt 1):125–132. doi: 10.4269/ajtmh.1978.27.125. [DOI] [PubMed] [Google Scholar]
- Poland J. D., Calisher C. H., Monath T. P., Downs W. G., Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ. 1981;59(6):895–900. [PMC free article] [PubMed] [Google Scholar]
- Robertson S. E., Hull B. P., Tomori O., Bele O., LeDuc J. W., Esteves K. Yellow fever: a decade of reemergence. JAMA. 1996 Oct 9;276(14):1157–1162. [PubMed] [Google Scholar]
- Valente J. F., Bull D. A., Fennerty B. P., Rappaport W. D. Gallstone pancreatitis. Choosing and timing treatment. Postgrad Med. 1991 Feb 1;89(2):123-4, 126-8, 130. doi: 10.1080/00325481.1991.11700820. [DOI] [PubMed] [Google Scholar]
- Van der Stuyft P., Gianella A., Pirard M., Cespedes J., Lora J., Peredo C., Pelegrino J. L., Vorndam V., Boelaert M. Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet. 1999 May 8;353(9164):1558–1562. doi: 10.1016/s0140-6736(99)03291-2. [DOI] [PubMed] [Google Scholar]
- Vasconcelos P. F., Rodrigues S. G., Degallier N., Moraes M. A., da Rosa J. F., da Rosa E. S., Mondet B., Barros V. L., da Rosa A. P. An epidemic of sylvatic yellow fever in the southeast region of Maranhao State, Brazil, 1993-1994: epidemiologic and entomologic findings. Am J Trop Med Hyg. 1997 Aug;57(2):132–137. doi: 10.4269/ajtmh.1997.57.132. [DOI] [PubMed] [Google Scholar]
- Walter S. D., Hildreth S. W., Beaty B. J. Estimation of infection rates in population of organisms using pools of variable size. Am J Epidemiol. 1980 Jul;112(1):124–128. doi: 10.1093/oxfordjournals.aje.a112961. [DOI] [PubMed] [Google Scholar]
- Wang E., Weaver S. C., Shope R. E., Tesh R. B., Watts D. M., Barrett A. D. Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa. Virology. 1996 Nov 15;225(2):274–281. doi: 10.1006/viro.1996.0601. [DOI] [PubMed] [Google Scholar]
- Westaway E. G., Brinton M. A., Gaidamovich SYa, Horzinek M. C., Igarashi A., Käriäinen L., Lvov D. K., Porterfield J. S., Russell P. K., Trent D. W. Flaviviridae. Intervirology. 1985;24(4):183–192. doi: 10.1159/000149642. [DOI] [PubMed] [Google Scholar]